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Abstract
Glioblastomas known for their adverse outcomes are
most reportedly managed by surgical resection. Studies
on the impact of (Extent of Resection) EOR against Quality
of Life (QOL) are very limited. We have collected data from
recent studies in this review to extract a general
consensus among the neurosurgeons regarding the EOR.
Key parameters like functional independence,
neurocognitive improvements and global health status
have been explored in the context of QOL. The currently
available data suggests that an increased EOR may help
improve QOL in GBM patients. With the help of recent
advancements it may be possible to attain a better extent
of resection while operating on GBMs.
Keywords: Glioblastoma, Quality of Life, Resection
margins, Prognosis.
Introduction
GBM patients by convention have low quality of life, as
well as a very low survival rate (14 months with surgical
and adjuvant treatments to 5 month with no treatment).1
The quality of life (QOL) can be assessed by using a
number of parameters like functional independence,
surgical morbidity, neurocognitive functions and
postoperative deficits using KPS scores and EuroQol
inventories.
Review of Evidence
The relation between the extent of resection (EOR) and
the quality of life (QOL) of GBM patients after surgery is a
topic that has not been explored extensively. Jakola et al
stated a study of 88 GBM patients in which surgical
resection had no significant alteration in the quality of life.
The Karnofsky Performance Scale (KPS) scores had
improved in 24.1% patients, however they were equal in
47.2% and had deteriorated in 28.7% of all cases. The
EuroQol 5D tests (EQ-5D) results had improved in 35.2%,
were equal in 20.5% and had deteriorated in 28% of all
cases. However they mentioned non usage of
intraoperative ultrasonography on the resection control
group as an indicator of worsening QOL (p=0.021). This
indirectly indicates the correlation of QOL with EOR as
intraoperative ultrasonography could have possibly
helped in attaining a more desirable resection threshold
and help the surgeon decide the most suitable EOR.2 The
association of prolonged functional independence (PFI)
with gross total resection (GTR) was documented in a
study by Chaichana et al. In this study of 544 patients, the
researchers pointed a positive association of PFI with GTR
(p<0.0001). The functional independence was mentioned
to be a part of improving QOL. They also utilized Fisher
exact analysis to determine an association of increasing
EOR with postoperative motor deficits. They found no
statistical relation between the two (p=0.28).3 This,
however, pointed an improvement in the QOL of patients
with a maximum EOR value. In another study by Adam
Sacho et al on 84 patients showed that the surgical
resection had a statistically significant relation with
increased survival with functional independence
(p=0.006), thus, with an improved QOL.4 Similarly Brown
et al in their study of 124 patients pointed that GTR was
better related with higher QOL (p=0.003) compared to
subtotal resection (STR).5
Another study, by Yukitaka Ushio et al, however had
negative outcomes in this aspect. GTR was performed on
35 patients (33%), partial resection (PR) on 57 patients
(54%) and biopsy in 13 patients (12%). The researchers
presented no significant change in KPS scores of PR and
biopsy groups (70% to 72% and 64% to 62% respectively).
Although some improvements were seen in the KPS
scores of GTR group (78% to 83%) yet still, the results were
mentioned to be not statistically significant.6
A study by Oppenlander et al evaluated 170 patients. The
researchers observed a deterioration of NIH Stroke Scale
in higher number of patients with a higher EOR compared
with patients with lower EOR (39.1% of the patients with
EOR >80% against the 16.7% of patients with EOR <80%).
They did note that the increase in neurological morbidity
did not continue more than 30 days postoperatively
(p=0.1279). This indirectly points to a short but negative
association of EOR with QOL.7 This stands in contrast to a
study by Hoffermann et al where the researchers noticed
a decrease in surgical morbidity of the 124 patients
selected in GTR compared with STR and PR. The
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decrement, however, was not of statistical significance
(p=0.06).8
A recent prospective study by Jakola AS et al of 16 patients
also showcased an improvement of QOL in patients with
higher EOR. The researchers mentioned the median EOR
to be 93% (IQR 78-99). 24% had GTR. They found an
increase of 0.11 in the EQ-5D scores of the patients from a
preoperative score of 0.34±0.38 to a score of 0.45±0.32 in
the postoperative tests (p=0.30), although, 3 patients had
a deterioration in QOL after surgery.9 A longitudinal study
by Diagle K et al pointed the improvement of QOL in larger
EOR performed patients as well. Of 35 patients selected,
the researchers used different EORs. The Sherbrooke
Neuro-oncology assessment scale was used for QOL
assessment. Better QOL scores were mentioned across all
domains when resection was
compared to biopsies.
Compared within the EOR
differences, functional
wellbeing and neurocognitive
functions were observed as
being the most improved QOL
domains (r=0.0616, p=0.005 and
r=0.51, p=0.026 respectively).10
Similarly, Suchorska B et al
noted a higher association of
general motor dysfunction of
the patients that underwent
incomplete resection compared
with the ones that had complete
tumour resection (p=0.04).
Likewise, the complete
resection cohort had better
global health status (p=0.008).11
Conclusion
The parallel review of all the
studies under consideration
tends to point a positive
association between increased
extent of resection (EOR) and
higher quality of life (QOL). The
patient cohorts that underwent
gross total resection had the
most benefit in terms of QOL,
although, the cohorts with
subtotal resection still benefited
in accordance of their EOR. The
improvements were reported
across all domains, particularly
in the domain of functional
independence of the patients.
Surgical morbidity has been
reported as a risk, despite its brief presence after surgery
or its absence altogether. Although the dominant effect
of increased EOR with improved QOL can be illustrated by
this review. There is a pressing need for establishment of
a higher level of evidence in this aspect.
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